Johnson & Johnson SURGIFLO* Haemostatic Matrix - HSA Registration DE0008721
Access comprehensive regulatory information for Johnson & Johnson SURGIFLO* Haemostatic Matrix in the Singapore medical device market through Pure Global AI's free database. This CLASS D medical device is registered under HSA registration number DE0008721 and owned by Ferrosan Medical Devices A/S. The device was registered on March 07, 2012.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
SURGIFLO Haemostatic Matrix, saturated with sterile solution, is indicated for surgical procedures (except ophthalmic) for hemostasis, when control of capillary, venous and arteriolar bleeding by pressure, ligature and other conventional procedures is ineffective or impractical. Although not necessary, SURGIFLO Haemostatic Matrix can be used with thrombin to achieve haemostasis